Company News
Beta Drugs Forms $8.7M Algeria Oncology JV
Beta Drugs forms 49% JV with IMGSA to acquire oncology plant for $8.7M in Algeria.
JV will leverage IMGSA's distribution network to serve Algeria's $1B oncology tender market.
Beta to invest $3M over